The most frequent drug-related adverse events in the 1/3 and 3/4 treatment arms , respectively , were alanine aminotransferase ( ALT ) level increases ( 68 % vs. 63 % ) , nausea ( 56 % vs. 59 % ) , and asthenia ( 56 % vs. 48 % ) .